Podcasts · Science · Business

Pharma Market Access Insights - from Petauri Evidence

Petauri Evidence

74 episodes

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.

Episodes page 1 of 2

  1. Designing a Global Market Access Strategy Built for MFN

    · 1 h 00 min · S9 E9

    Send us Fan Mail How will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for…

  2. LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico

    · 57 min · S9 E8

    Send us Fan Mail How do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina,…

  3. The Evolving NHS – An ICS Chief Pharmacist’s Perspective

    · 31 min · S8 E7

    Send us Fan Mail What does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams responding? In this Petauri Evidence NHS Whispers…

  4. First to Market: Unlocking Switzerland’s Pharma Potential

    · 45 min · S8 E6

    Send us Fan Mail What makes Switzerland a compelling first-launch market for Pharma? How does its healthcare system compare to other European countries? What do manufacturers need to know about reimbursement, pricing,…

  5. Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice

    · 1 h 00 min · S8 E5

    Send us Fan Mail In this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to: - Sarah Everest Ford (Programme Director, Health and Care Partnership) -…

  6. Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

    · 53 min · S8 E4

    Send us Fan Mail Uncover the forces driving change in global pricing and access In this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market…

  7. Transforming Global Market Access: Smarter Resource Management with Local Affiliates

    · 34 min · S8 E3

    Send us Fan Mail Discover a smarter way to manage and share market access resources with local affiliates Are your global market access resources scattered, leading to inconsistencies and confusion among your…

  8. Communicating value to US Payers: Insights for Pharma and Medtech

    · 59 min · S8 E2

    Send us Fan Mail What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you…

  9. Navigating market access: Launch strategies and health economic modelling for medical devices

    · 45 min · S8 E1

    Send us Fan Mail Discover how health economics can support successful Medical Device launch, proposition development, and market access This episode offers an insightful journey into the world of medical device market…

  10. Navigating US payer evidence needs to optimise market access

    · 58 min · S7 E23

    Send us Fan Mail What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be…

  11. Best practice RWE approaches to support economic modelling for HTA

    · 1 h 00 min · S7 E22

    Send us Fan Mail How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment…

  12. NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas

    · 1 h 03 min · S7 E21

    Send us Fan Mail How is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months? In August,…

  13. De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

    · 56 min · S7 E20

    Send us Fan Mail Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a new health technology to the…

  14. NHS primary care panel – the GP Contract and Operational Planning Guidance

    · 1 h 02 min · S7 E19

    Send us Fan Mail What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the…

  15. Engage NHS healthcare decision-makers with RWD

    · 21 min · S7 E18

    Send us Fan Mail Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting…

  16. Market access and reimbursement in Canada – changes at CADTH

    · 48 min · S5 E17

    Send us Fan Mail What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In…

  17. Rare Disease market access in the MENA and Nordic regions

    · 59 min · S5 E16

    Send us Fan Mail Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have…

  18. How does funding flow in NHSE Regions?

    · 1 h 00 min · S5 E15

    Send us Fan Mail Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders? We sit down with guest…

  19. NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

    · 1 h 02 min · S5 E14

    Send us Fan Mail What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on…

  20. De-mystifying health economic model classifications and structures

    · 1 h 00 min · S5 E13

    Send us Fan Mail What is health economic evaluation and which modelling approaches can be used to support market access activities? In this episode, our expert health economists explain the key strengths and…

  21. Evidence strategy for Medical Technologies and Diagnostics

    · 53 min · S5 E12

    Send us Fan Mail Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic…

  22. How to set your Pharma or Medtech product up for success in the US market

    · 43 min · S5 E11

    Send us Fan Mail How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice…

  23. What's happening with specialised commissioning in the NHS?

    · 1 h 00 min · S5 E10

    Send us Fan Mail What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this…

  24. Integrated care in NHS Wales – what can England learn from its neighbour?

    · 56 min · S5 E9

    Send us Fan Mail What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England? Paul Mears (CEO, Cwm Taf Morgannwg…

  25. Market access in Italy: Reforms at AIFA

    · 44 min · S5 E8

    Send us Fan Mail Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer)…

  26. Unmet need in NHS primary care – How can industry best support PCN leaders?

    · 1 h 01 min · S5 E7

    Send us Fan Mail Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how…

  27. Population health management: a community effort across health and life sciences

    · 1 h 04 min · S5 E6

    Send us Fan Mail How can our community support NHS leaders to deliver a data-led, people-centric health service? Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief…

  28. Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

    · 40 min · S5 E5

    Send us Fan Mail How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean…

  29. 6 areas of UK health policy for Medtech to pay attention to

    · 1 h 02 min · S5 E4

    Send us Fan Mail How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks…

  30. Market access in the German speaking markets

    · 58 min · S5 E3

    Send us Fan Mail Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS…

  31. The role of nursing in driving digital change in the NHS

    · 55 min · S4 E5

    Send us Fan Mail How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can…

  32. Market access for digital therapies and digital medicines

    · 42 min · S5 E2

    Send us Fan Mail In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and…

  33. A global market access journey in cannabinoid pharmaceuticals

    · 54 min · S5 E1

    Send us Fan Mail What does it take to bring a cannabinoid pharmaceutical to market? We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar…

  34. Primary Care and ICBs – what is the next step in the integration journey?

    · 1 h 01 min · S4 E4

    Send us Fan Mail How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows…

  35. Data-led transformation in the NHS - partnering to optimise patient care

    · 1 h 03 min · S4 E3

    Send us Fan Mail Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the…

  36. Innovating for better health – research, collaboration and innovation in the NHS

    · 58 min · S4 E2

    Send us Fan Mail How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia? What…

  37. Healthcare, economics and society – unlocking NHS collaboration

    · 59 min · S4 E1

    Send us Fan Mail Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider population they…

  38. Specialised Commissioning in the NHS – What do you need to know now

    · 1 h 01 min · S2 E24

    Send us Fan Mail The proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways…

  39. Why are we waiting? - Pressures facing the NHS and how to deliver change

    · 1 h 01 min · S2 E23

    Send us Fan Mail With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with…

  40. Priority setting in primary care - NHS insights

    · 1 h 00 min · S2 E22

    Send us Fan Mail How is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care? Dr Alex Degan (Primary…

  41. Integrated Care Systems go live in the NHS - reflections after 3 weeks

    · 1 h 00 min · S2 E21

    Send us Fan Mail On 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients? What are the…

  42. Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

    · 1 h 01 min · S2 E20

    Send us Fan Mail What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? Tom Clarke…

  43. Transforming systems and care pathways for an integrated NHS

    · 1 h 01 min · S2 E19

    Send us Fan Mail As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and…

  44. Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

    · 39 min · S3 E3

    Send us Fan Mail Our experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market…

  45. Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

    · 56 min · S2 E18

    Send us Fan Mail What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look…

  46. Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

    · 59 min · S2 E17

    Send us Fan Mail What does the ‘2022/23 priorities and operational planning guidance’ document mean for the NHS, for Integrated Care System (ICS) development and for an NHS workforce still battling COVID? How…

  47. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

    · 1 h 03 min · S2 E16

    Send us Fan Mail Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and…

  48. Optimising the NHS – How will medicines be valued in integrated systems?

    · 54 min · S2 E15

    Send us Fan Mail How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what does this mean for market access?…

  49. Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

    · 1 h 01 min · S3 E2

    Send us Fan Mail We explore the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are faced with a…

  50. A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)

    · 1 h 00 min · S2 E14

    Send us Fan Mail How are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits…

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.